ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $307,000 | -24.9% | 6,987 | -15.7% | 0.05% | 0.0% |
| Q1 2021 | $409,000 | -24.4% | 8,286 | -35.5% | 0.05% | -23.9% |
| Q4 2020 | $541,000 | +14.4% | 12,854 | +24.4% | 0.07% | +18.3% |
| Q3 2020 | $473,000 | -11.3% | 10,332 | -2.6% | 0.06% | -11.8% |
| Q2 2020 | $533,000 | -57.6% | 10,611 | -56.6% | 0.07% | -59.3% |
| Q1 2020 | $1,257,000 | +383.5% | 24,432 | +479.6% | 0.17% | +288.4% |
| Q4 2019 | $260,000 | – | 4,215 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |